Bladder cancer, malignant (ICD10 C67): combined sexes

Five-year relative survival by diagnosis year and age at diagnosis

	Five-year relative survival (with 95% confidence interval) by diagnosis year				EUROCARE-4	EUROCARE-4
Age at diagnosis	1994-97	1998-2002	2003-2007	2007-2009	##1995-1999	##1995-1999
	cohort	cohort	cohort	*hybrid	Ireland	Europe average
	malignant	malignant	malignant	malignant	all behaviours	all behaviours

all 15-99	69.7%	70.6%	69.4%	68.0%
(unstandardized)	(66.5-72.7%)	(67.7-73.4%)	(65.9-72.7%)	(64.4-71.4%)

all 15-99	70.1%	71.2%	69.2%	68.6%	72.4%	72.4%
(age-standardized)#	(63.8-75.7%)	(65.6-76.1%)	(61.9-75.5%)	(61.1-75.0%)	(69.9-75.0%)	(71.9%-72.8%)

15-44	81.8%	89.1%	69.4%	69.6%
	(69.2-89.7%)	(79.0-94.6%)	(52.2-81.6%)	(53.4-81.2%)

45-54	84.8%	86.5%	80.9%	83.5%
	(77.0-90.0%)	(80.1-91.2%)	(72.9-86.9%)	(74.7-89.6%)

55-64	79.3%	78.9%	78.3%	77.4%
	(73.8-84.0%)	(73.8-83.4%)	(72.0-83.5%)	(70.4-83.1%)

65-74	66.1%	69.4%	71.4%	71.8%
	(61.1-70.8%)	(64.7-73.7%)	(65.8-76.5%)	(65.8-77.2%)

75-99	57.9%	56.2%	54.7%	52.2%
	(51.3-64.4%)	(50.7-61.9%)	(47.6-61.8%)	(45.4-59%)

Footnotes:

*Hybrid estimate for 2007-2009 is the most up-to-date survival estimate and is based on follow-up of all cases alive at any point during this period,

supplemented by follow-up 2005-2009 for cases diagnosed in 2005 or 2006 (to provide more reliable estimation of the first two years of survival).

In practice, the hybrid estimate for 2007-2009 is similar to the most recent (incomplete) cohort, i.e. cases diagnosed 2003-2007, reflecting substantial overlap of data.

# Age-standardized figures use the standard patient population proposed for this cancer by:

Corazziari I., Quinn M. & Capocaccia R. 2004. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40: 2307-2316.

(Population weights = age 15-44 x7000, 45-54 x12000, 55-64 x23000, 65-74 x29000, 75-99 x29000)

## For comparison, the age-standardized average survival is quoted for countries (including Ireland) that participated in the EUROCARE-4 study:

Sant M. et al. 2009. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 45: 931-991.

Exclusions:

Patients aged <15 or >99 at diagnosis; death-certificate-only (DCO) and autopsy-only cases; second or subsequent malignancies in the same patient

(or the less serious of two or more synchronously-diagnosed malignancies); in situ carcinomas and tumours of uncertain behaviour (INCLUDED by EUROCARE).

Cancer registration is a dynamic process and information is continually updated on our database.

As a result, the figures given here may not correspond exactly to those in previous reports or to those previously shown on our website.